Advanced Search

    column
    ASCO Hot: Thoughts about Lung Cancer Immunotherapy
    WU Yi-long
    2015, 15(3): 129-129. DOI: 10.3969/j.issn.1671-5144.2015.03.001
    Abstract PDF
    SABR Challenge Surgery in the Treatment of Early Non-Small Cell Lung Cancer
    TAN Pei-xin, PAN Yi
    2015, 15(3): 130-130. DOI: 10.3969/j.issn.1671-5144.2015.03.002
    Abstract PDF
    Cavity Shaving to Reduce the Rates of Positive Margins and Reexcision Among Patients Undergoing Breast-Conserving Surgery for Breast Cancer
    CHENG Min-yi, WANG Kun
    2015, 15(3): 131-131. DOI: 10.3969/j.issn.1671-5144.2015.03.003
    Abstract PDF
    Two Immune Checkpoint Inhibitors in PhaseⅠ Clinical Study of Efficacy
    LIAO Ri-qiang, YANG Xue-ning
    2015, 15(3): 132-133. DOI: 10.3969/j.issn.1671-5144.2015.03.004
    Abstract PDF
    Inspiration and Innovation: 2015 Adjuvant Endocrine Therapy for Breast Cancer
    LIAO Ning
    2015, 15(3): 134-137. DOI: 10.3969/j.issn.1671-5144.2015.03.005
    Abstract PDF
    Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
    LIU Jian, HUANG Wei-wei, ZHANG Yi-fang
    2015, 15(3): 138-140. DOI: 10.3969/j.issn.1671-5144.2015.03.006
    Abstract PDF
    Addition of Bevacizumab to Endocrine Therapy as First-Line Treatment for Advanced Breast Cancer Cannot Increase in Survival
    LIN Ying, SHAO Nan, REN Chong-yang
    2015, 15(3): 141-143. DOI: 10.3969/j.issn.1671-5144.2015.03.007
    Abstract PDF
    Goserelin for Ovarian Protection during Breast Cancer Adjuvant Chemotherapy
    ZHANG Jin, ZHANG Liu-lu
    2015, 15(3): 144-145. DOI: 10.3969/j.issn.1671-5144.2015.03.008
    Abstract PDF
    Palbociclib in Combination with Letrozole Versus Letrozole alone as First-Line Treatment of Oestrogen Receptor Positive, HER2-Negative, Advanced Breast Cancer Significantly Improve Progression-Free Survivial
    WANG Shu-sen, YU Hong-yan
    2015, 15(3): 146-148. DOI: 10.3969/j.issn.1671-5144.2015.03.009
    Abstract PDF
    A Meta Analysis of the Pharmacological Effect of Sitagliptin in the Treatment of Type 2 Diabetes Mellitus
    LI Yin-hui, LI Kai-li, LIU Hao
    2015, 15(3): 149-154. DOI: 10.3969/j.issn.1671-5144.2015.03.010
    Abstract PDF
    A Retrospective Study of the Predictive Value of [18F]-FDG PET to Neoadjuvant Chemotherapy of Breast Cancer
    WEN Ling-zhu, LÜ Hai-tong, REN Chong-yang, ZHANG Guo-chun, LIAO Ning
    2015, 15(3): 155-160. DOI: 10.3969/j.issn.1671-5144.2015.03.011
    Abstract PDF
    The Effect of Alprostadil on the Prevention of Contrast-Induced Nephropathy in Patients Undertaking Coronary Angiography: A Meta-Analysis
    ZHAN Bi-ming, PAN Xiong, SUN Wen-hua, HU Jian-xin
    2015, 15(3): 161-167. DOI: 10.3969/j.issn.1671-5144.2015.03.012
    Abstract PDF
    Meta Analysis of the Combination of TACE and Resection for Treatment of HCC in Chinese
    LEI Jun, FAN Yu-xiang, HE Wen-ting, ZENG Fang-ye, SUN Qi, ZHANG Hong-liang
    2015, 15(3): 168-176. DOI: 10.3969/j.issn.1671-5144.2015.03.013
    Abstract PDF
    Characterization of Dry Eye Disease in Elder Diabetes Versus Nondiabetes
    ZHU Ling, YANG Xiao-hong, DENG Hai-ou, LIN Kai
    2015, 15(3): 177-179. DOI: 10.3969/j.issn.1671-5144.2015.03.014
    Abstract PDF
    The Classification, Statistical Methods, Assumption and Evidence Quality Assessment of Network Meta Analysis
    LI Lun, TIAN Jin-hui, YAO Liang, CHEN Yao-long, YANG Kehu
    2015, 15(3): 180-183. DOI: 10.3969/j.issn.1671-5144.2015.03.015
    Abstract PDF
    The Controversy and Progress of Regional Lymphadenectomy in Squamous Cell Carcinoma of the Penis
    TANG Yong, LU Hao-yuan, YI Xian-lin, LI Xiu-ning, GAO Chao, LIU Han-nan, BAI Xian-zhong
    2015, 15(3): 184-188. DOI: 10.3969/j.issn.1671-5144.2015.03.016
    Abstract PDF
    Diagnosis and Treatment for Ground-Glass Opacity Lesion with Gradual Progression in Pulmonary
    HAN Jie-fei, LOU Na-na, ZHANG Qi
    2015, 15(3): 189-192. DOI: 10.3969/j.issn.1671-5144.2015.03.017
    Abstract PDF